DE69529499D1 - Stereoselektives Verfahren zur Herstellung von Dihydro-2,3-benzodiazepin-Derivaten - Google Patents

Stereoselektives Verfahren zur Herstellung von Dihydro-2,3-benzodiazepin-Derivaten

Info

Publication number
DE69529499D1
DE69529499D1 DE69529499T DE69529499T DE69529499D1 DE 69529499 D1 DE69529499 D1 DE 69529499D1 DE 69529499 T DE69529499 T DE 69529499T DE 69529499 T DE69529499 T DE 69529499T DE 69529499 D1 DE69529499 D1 DE 69529499D1
Authority
DE
Germany
Prior art keywords
dihydro
preparation
benzodiazepine derivatives
stereoselective process
stereoselective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69529499T
Other languages
English (en)
Other versions
DE69529499T2 (de
Inventor
Benjamin Anderson
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Milton Joseph Zmijewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69529499D1 publication Critical patent/DE69529499D1/de
Application granted granted Critical
Publication of DE69529499T2 publication Critical patent/DE69529499T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69529499T 1994-08-31 1995-08-30 Stereoselektives Verfahren zur Herstellung von Dihydro-2,3-benzodiazepin-Derivaten Expired - Lifetime DE69529499T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (2)

Publication Number Publication Date
DE69529499D1 true DE69529499D1 (de) 2003-03-06
DE69529499T2 DE69529499T2 (de) 2003-12-04

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69529499T Expired - Lifetime DE69529499T2 (de) 1994-08-31 1995-08-30 Stereoselektives Verfahren zur Herstellung von Dihydro-2,3-benzodiazepin-Derivaten

Country Status (22)

Country Link
US (3) US5919954A (de)
EP (1) EP0699677B1 (de)
JP (1) JP3481019B2 (de)
KR (1) KR100399518B1 (de)
CN (1) CN1086705C (de)
AT (1) ATE231867T1 (de)
AU (1) AU702658B2 (de)
BR (1) BR9503845A (de)
CA (1) CA2157234C (de)
CZ (1) CZ295675B6 (de)
DE (1) DE69529499T2 (de)
DK (1) DK0699677T3 (de)
ES (1) ES2189819T3 (de)
FI (1) FI113269B (de)
HK (1) HK1013818A1 (de)
HU (1) HU223776B1 (de)
IL (1) IL115100A (de)
IN (1) IN190402B (de)
NO (1) NO312838B1 (de)
PL (3) PL188796B1 (de)
RU (1) RU2151149C1 (de)
TR (1) TR199501071A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1271360A (zh) * 1997-08-12 2000-10-25 埃吉斯药物工厂 作为ampa/红藻氨酸受体抑制剂的1,3－二氧杂环戊烷并/4,5－h//2,3/苯并－二氮杂䓬衍生物
UA67749C2 (uk) 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
WO1999023242A1 (en) * 1997-11-04 1999-05-14 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
ATE425817T1 (de) * 2005-12-05 2009-04-15 Deutsche Post Ag Verfahren zum sortieren von postsendungen und vorrichtung mit einer datenstruktur fur einen sortierplan
AU2006334172A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
EP0357787B1 (de) * 1988-02-12 1996-05-08 Daicel Chemical Industries, Ltd. Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性（ｓ）−２−クロロ−１−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd Ｄ−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
CZ295675B6 (cs) 2005-09-14
PL188796B1 (pl) 2005-04-29
KR960007595A (ko) 1996-03-22
HU9502545D0 (en) 1995-10-30
KR100399518B1 (ko) 2004-04-30
FI113269B (fi) 2004-03-31
IL115100A (en) 2000-07-26
DK0699677T3 (da) 2003-04-22
CA2157234A1 (en) 1996-03-01
TR199501071A2 (tr) 1996-06-21
BR9503845A (pt) 1996-04-16
HK1013818A1 (en) 1999-09-10
RU2151149C1 (ru) 2000-06-20
CN1123282A (zh) 1996-05-29
AU702658B2 (en) 1999-02-25
HU223776B1 (hu) 2005-01-28
NO953396L (no) 1996-03-01
EP0699677B1 (de) 2003-01-29
IL115100A0 (en) 1995-12-08
AU3035595A (en) 1996-03-14
CN1086705C (zh) 2002-06-26
PL310226A1 (en) 1996-03-04
NO953396D0 (no) 1995-08-30
ES2189819T3 (es) 2003-07-16
DE69529499T2 (de) 2003-12-04
JPH0881468A (ja) 1996-03-26
CZ221995A3 (en) 1996-03-13
US6160133A (en) 2000-12-12
NO312838B1 (no) 2002-07-08
FI954064A0 (fi) 1995-08-30
HUT72644A (en) 1996-05-28
CA2157234C (en) 2005-05-03
US5986114A (en) 1999-11-16
JP3481019B2 (ja) 2003-12-22
FI954064A (fi) 1996-03-01
PL190318B1 (pl) 2005-11-30
PL190640B1 (pl) 2005-12-30
US5919954A (en) 1999-07-06
ATE231867T1 (de) 2003-02-15
EP0699677A1 (de) 1996-03-06
IN190402B (de) 2003-07-26

Similar Documents

Publication Publication Date Title
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
DE60040905D1 (de) VERFAHREN ZUR HERSTELLUNG VON (E)-(6-i2-i4-(4-FLUORPHENYL)-6-ISOPROPYL-2-iMETHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL VINYL (4R,6S)-2,2-DIMETHYLi1,3 DIOXAN-4-YL)ESSIGSÄURE-TERT-BUTYLESTER
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
DE69529499T2 (de) Stereoselektives Verfahren zur Herstellung von Dihydro-2,3-benzodiazepin-Derivaten
ATE51617T1 (de) Verfahren zur herstellung von 4-phenyl-pyrrolderivaten.
DE69704832T2 (de) Verfahren zur Herstellung von Pyrimidinderivaten
DE69925992D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-HYDROXYBENZO[b]THIOPHEN-3-CARBONSÄURE
MY117754A (en) Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives
MA23268A1 (fr) Procede de preparation de composes azacyliques heterocycliques utiles comme antagonistes des recepteurs d'natagonisne ii.
AU3210593A (en) Improvements in or relating to organic compounds
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE59809538D1 (de) Verfahren zur Herstellung von 1,2,3,6-Tetrahydro-2,2,6,6-tetramethylpyridin
DE59806309D1 (de) Verfahren zur Herstellung von 1,2,3,6-Tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl
ATE160147T1 (de) Verfahren zur herstellung von enantiomer reinem imidazo (4,5,1-jk) (1,4)-benzodiazepin-2(1h)- thionen
DE69500362D1 (de) Verfahren zur Herstellung 5,6-dihydroxyindol-Derivate ausgehend von Dopa
DE60006026D1 (de) Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte
DE69816773D1 (de) Verfahren zur herstellung von 1,4-benzodioxan-derivaten
DE59812729D1 (de) Verfahren zur Herstellung von 1,3-Dioxanverbindungen
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister
DE69834853D1 (de) 1H-pyrrolo i1,2-böi1,2,4ötriazolederivate, Zwischenprodukte und Verfahren zur Herstellung von 1H-1,2,4,-triazol-5-yl Essigsäureesterderivate
DE3864463D1 (de) Gamma-l-glutanyl-4-nitoanilid-derivate und verfahren zur bestimmung von gamma-gtp-aktivitaet unter verwendung dieser derivate.
DE3683352D1 (de) Verfahren zur herstellung von indolinen.
BR9610392A (pt) Processo para a preparação de derivados de rodanina substituídos com benzila
DE59709211D1 (de) Verfahren zur Herstellung von 4,6-Dihydroxypyrimidin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition